Creative Medical Technology Holdings, Inc.
CELZ
$1.93
-$0.05-2.53%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 3.00K | -- | 8.00K | -- | 3.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.00K | -- | 8.00K | -- | 3.00K |
| Cost of Revenue | 1.20K | -- | 3.20K | -- | 1.20K |
| Gross Profit | 1.80K | -- | 4.80K | -- | 1.80K |
| SG&A Expenses | 1.39M | 498.60K | 676.10K | 671.50K | 1.40M |
| Depreciation & Amortization | 22.60K | 29.30K | 29.30K | 29.30K | 25.50K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.89M | 1.11M | 1.63M | 1.12M | 1.77M |
| Operating Income | -1.89M | -1.11M | -1.63M | -1.12M | -1.77M |
| Income Before Tax | -1.85M | -1.04M | -1.56M | -1.04M | -1.68M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.85M | -1.04M | -1.56M | -1.04M | -1.68M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.85M | -1.04M | -1.56M | -1.04M | -1.68M |
| EBIT | -1.89M | -1.11M | -1.63M | -1.12M | -1.77M |
| EBITDA | -1.86M | -1.08M | -1.60M | -1.09M | -1.75M |
| EPS Basic | -1.09 | -0.75 | -1.11 | -0.73 | -1.22 |
| Normalized Basic EPS | -0.68 | -0.47 | -0.69 | -0.46 | -0.76 |
| EPS Diluted | -1.09 | -0.75 | -1.11 | -0.73 | -1.22 |
| Normalized Diluted EPS | -0.68 | -0.47 | -0.69 | -0.46 | -0.76 |
| Average Basic Shares Outstanding | 1.70M | 1.39M | 1.41M | 1.42M | 1.38M |
| Average Diluted Shares Outstanding | 1.70M | 1.39M | 1.41M | 1.42M | 1.38M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |